0001781174-21-000002.txt : 20211123 0001781174-21-000002.hdr.sgml : 20211123 20211123155504 ACCESSION NUMBER: 0001781174-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211123 DATE AS OF CHANGE: 20211123 EFFECTIVENESS DATE: 20211123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc. CENTRAL INDEX KEY: 0001781174 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-422273 FILM NUMBER: 211438391 BUSINESS ADDRESS: STREET 1: LAB CENTRAL STREET 2: 700 NORTH MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-888-0830 MAIL ADDRESS: STREET 1: LAB CENTRAL STREET 2: 700 NORTH MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001781174 Acrivon Therapeutics, Inc. 480 Arsenal Way Suite 100 Watertown MA MASSACHUSETTS 02472 617-207-8979 DELAWARE None None Corporation true 2018 Peter Blume-Jensen 480 Arsenal Way Suite 100 Watertown MA MASSACHUSETTS 02472 Executive Officer Director Marcin Czernik 480 Arsenal Way Suite 100 Watertown MA MASSACHUSETTS 02472 Director Derek DiRocco 480 Arsenal Way Suite 100 Watertown MA MASSACHUSETTS 02472 Director Kristina Masson 480 Arsenal Way Suite 100 Watertown MA MASSACHUSETTS 02472 Executive Officer Director Sharon Shacham 480 Arsenal Way Suite 100 Watertown MA MASSACHUSETTS 02472 Director Eric Devroe 480 Arsenal Way Suite 100 Watertown MA MASSACHUSETTS 02472 Executive Officer Erick Gamelin 480 Arsenal Way Suite 100 Watertown MA MASSACHUSETTS 02472 Executive Officer Biotechnology Decline to Disclose 06b false 2021-11-09 false true false 0 99999974 99999974 0 false 13 0 0 0 false Acrivon Therapeutics, Inc. /s/ Peter Blume-Jensen Peter Blume-Jensen President 2021-11-22